Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Background and Objectives: Real-world evidence of apixaban treatment in patients with chronic kidney disease remains scarce. This study aimed to compare the relative risk of stroke or systemic embolism (SE) and major bleeding between apixaban and warfarin in atrial fibrillation (AF) patients with di...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2021-10-01
|
| Serija: | Frontiers in Cardiovascular Medicine |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.752468/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|